HomeAI · summaries
Storia in 3 fonti
Clinical trial finds aspirin reduces colon cancer recurrence by half - UPI.com
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska Institute clinical trial found.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
theguardian.com
Aspirin can have ‘huge effect’ in stopping colorectal cancer returning, study finds
Swedish researchers find low daily dose can halve risk in post-surgery patients with specific gene mutations
- ·
upi.com
Clinical trial finds aspirin reduces colon cancer recurrence by half - UPI.com
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska Institute clinical trial found.
